Cent Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CENT PHARMS, and what generic and branded alternatives to CENT PHARMS drugs are available?
CENT PHARMS has ten approved drugs.
Summary for Cent Pharms
| US Patents: | 0 |
| Tradenames: | 10 |
| Ingredients: | 6 |
| NDAs: | 10 |
Drugs and US Patents for Cent Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cent Pharms | THEOCLEAR-80 | theophylline | SYRUP;ORAL | 087095-001 | Mar 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Cent Pharms | PREDNISOLONE ACETATE | prednisolone acetate | INJECTABLE;INJECTION | 084717-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Cent Pharms | SYNOPHYLATE | theophylline sodium glycinate | ELIXIR;ORAL | 006333-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Cent Pharms | PREDNISOLONE ACETATE | prednisolone acetate | INJECTABLE;INJECTION | 084717-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Cent Pharms | THEOPHYLLINE | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 088654-001 | Feb 12, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Cent Pharms | THEOPHYLLINE | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 088689-001 | Feb 12, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
